Company / Operating Income per Share
Dianthus Therapeutics, Inc. /DE/ Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$5.72
FY2025
5-year range
-$33.98 / -$1.36
FY2021-FY2025
Trend
-75.9%
vs FY2024
Sector context
#176 of 201
Health Care
What the data says
Dianthus Therapeutics, Inc. /DE/'s operating income per share of $-5.72 is lower than 88% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-62.03 in FY2016 to $-1.36 in FY2021.
Based on SEC 10-K filings.
-5.72 in FY2025.
Improved from $-9.35 to $-5.72 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 201This company -$5.72 Sector average -$3.23
▼
-76.9% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 75.9% year-over-year.
- Ranks #176 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.72 | -75.9% |
| FY2024 | -$3.25 | +65.2% |
| FY2023 | -$9.35 | +72.5% |
| FY2022 | -$33.98 | -2399.7% |
| FY2021 | -$1.36 | +24.1% |
| FY2020 | -$1.79 | +28.1% |
| FY2019 | -$2.49 | +90.2% |
| FY2018 | -$25.50 | -32.5% |
| FY2017 | -$19.24 | +69.0% |
| FY2016 | -$62.03 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026